Article Versions Notes

Broege A, Rossetti S, Sen A, De La Forest A, Davis L, Seibel M, Menon AS, Stokke S, Macaulay A, Molden J, et al. Functional Analysis of the PI3K/AKT/mTOR Pathway Inhibitor, Gedatolisib, Plus Fulvestrant with and Without Palbociclib in Breast Cancer Models. International Journal of Molecular Sciences. 2025; 26(12):5844. https://doi.org/10.3390/ijms26125844

Broege, Aaron, Stefano Rossetti, Adrish Sen, Ann De La Forest, Laura Davis, Megan Seibel, Arul S. Menon, Sydney Stokke, Allison Macaulay, Jhomary Molden, and et al. 2025. "Functional Analysis of the PI3K/AKT/mTOR Pathway Inhibitor, Gedatolisib, Plus Fulvestrant with and Without Palbociclib in Breast Cancer Models" International Journal of Molecular Sciences 26, no. 12: 5844. https://doi.org/10.3390/ijms26125844

Broege, A., Rossetti, S., Sen, A., De La Forest, A., Davis, L., Seibel, M., Menon, A. S., Stokke, S., Macaulay, A., Molden, J., & Laing, L. (2025). Functional Analysis of the PI3K/AKT/mTOR Pathway Inhibitor, Gedatolisib, Plus Fulvestrant with and Without Palbociclib in Breast Cancer Models. International Journal of Molecular Sciences, 26(12), 5844. https://doi.org/10.3390/ijms26125844